🇺🇸 FDA
Pipeline program

ChimeriVax-JE, Japanese Encephalitis vaccine

H-040-010

Phase 3 mab completed

Quick answer

ChimeriVax-JE, Japanese Encephalitis vaccine for Encephalitis is a Phase 3 program (mab) at Sanofi Pasteur with 1 ClinicalTrials.gov record(s).

Program details

Company
Sanofi Pasteur
Indication
Encephalitis
Phase
Phase 3
Modality
mab
Status
completed

Clinical trials